Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$772M |
| 2 |
Eli Lilly
LLY
|
+$337M |
| 3 |
lululemon athletica
LULU
|
+$301M |
| 4 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$297M |
| 5 |
ResMed
RMD
|
+$273M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$576M |
| 2 |
AT&T
T
|
+$476M |
| 3 |
PNC Financial Services
PNC
|
+$393M |
| 4 |
Fortive
FTV
|
+$389M |
| 5 |
Accenture
ACN
|
+$374M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 2.83% |
| 2 | Technology | 2.79% |
| 3 | Financials | 2.29% |
| 4 | Consumer Discretionary | 1.93% |
| 5 | Industrials | 1.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2701
Aldeyra Therapeutics
ALDX
$94.1M
| $9.25M | ﹤0.01% |
2,318,178
-161,358
| -7% | -$555K |
|
|
SCOA
2702
DELISTED
ScION Tech Growth I Class A Ordinary Shares
SCOA
| $9.25M | ﹤0.01% |
935,891
-1,582,413
| -63% | -$15.6M |
|
2703
CALL
Carlyle Group
CG
$17.6B
| $9.24M | ﹤0.01% |
292,000
+106,500
| +57% | +$4.08M |
|
2704
CALL
Wendy's
WEN
$1.65B
| $9.24M | ﹤0.01% |
489,300
+318,900
| +187% | +$6.04M |
|
2705
McDonald's
MCD
$193B
| $9.24M | ﹤0.01% |
37,411
-86,527
| -70% | -$21.3M |
|
2706
PUT
Dutch Bros
BROS
$9.09B
| $9.23M | ﹤0.01% |
291,600
-253,800
| -47% | -$10.4M |
|
2707
CALL
Riot Platforms
RIOT
$7.14B
| $9.23M | ﹤0.01% |
2,202,100
-133,000
| -6% | -$1.23M |
|
2708
Talos Energy
TALO
$2.63B
| $9.22M | ﹤0.01% |
596,245
+239,125
| +67% | +$4.65M |
|
2709
PUT
Canadian National Railway
CNI
$76.7B
| $9.21M | ﹤0.01% |
81,900
+37,500
| +84% | +$4.38M |
|
2710
UFP Industries
UFPI
$4.96B
| $9.21M | ﹤0.01% |
135,172
+4,893
| +4% | +$369K |
|
2711
Omega Healthcare
OHI
$14.1B
| $9.21M | ﹤0.01% |
326,530
+9,455
| +3% | +$269K |
|
|
NOVA
2712
PUT
DELISTED
Sunnova Energy
NOVA
| $9.2M | ﹤0.01% |
499,400
-21,300
| -4% | -$407K |
|
2713
PUT
BlackBerry
BB
$5.22B
| $9.2M | ﹤0.01% |
1,706,200
+40,500
| +2% | +$240K |
|
2714
Nabors Industries
NBR
$1.39B
| $9.19M | ﹤0.01% |
68,634
+31,538
| +85% | +$4.94M |
|
2715
PUT
Ally Financial
ALLY
$13.7B
| $9.19M | ﹤0.01% |
274,200
-39,200
| -13% | -$1.57M |
|
|
OSH
2716
PUT
DELISTED
Oak Street Health, Inc.
OSH
| $9.18M | ﹤0.01% |
558,200
+287,200
| +106% | +$5.58M |
|
2717
PUT
Williams Companies
WMB
$92B
| $9.17M | ﹤0.01% |
293,900
-5,300
| -2% | -$183K |
|
2718
CALL
Deckers Outdoor
DECK
$12.7B
| $9.17M | ﹤0.01% |
215,400
-415,800
| -66% | -$18.1M |
|
|
2719
PUT
Deckers Outdoor
DECK
$12.7B
| $9.17M | ﹤0.01% |
215,400
-331,800
| -61% | -$14.5M |
|
2720
CALL
Ovintiv
OVV
$17.4B
| $9.16M | ﹤0.01% |
207,300
-69,300
| -25% | -$3.57M |
|
|
AXON
2721
PUT
Axon Enterprise
AXON
$49.8B
| $9.16M | ﹤0.01% |
98,300
+12,700
| +15% | +$1.34M |
|
|
AXON
2722
CALL
Axon Enterprise
AXON
$49.8B
| $9.15M | ﹤0.01% |
98,200
-39,900
| -29% | -$4.22M |
|
2723
CALL
IPG Photonics
IPGP
$3.65B
| $9.15M | ﹤0.01% |
97,200
+80,600
| +486% | +$7.97M |
|
|
CHNG
2724
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $9.13M | ﹤0.01% |
395,934
+38,239
| +11% | +$893K |
|
2725
Royal Gold
RGLD
$19.5B
| $9.11M | ﹤0.01% |
85,301
-195,447
| -70% | -$24.2M |
|
Similar funds
Ken Griffin's Q2 2022 Portfolio in Review
As of Q2 2022, Ken Griffin held 14,957 positions worth $390B, down 20% from $484B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Griffin's Q2 2022 filing shows 1,520 new, 5,503 increased, 5,522 reduced and 2,191 closed positions. Its largest new stake was ResMed: 1,280,595 shares worth $268M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $576M.
By sector, the portfolio is most concentrated in Healthcare at 2.8% of assets, up from 2.4% a quarter earlier, followed by Technology and Financials.
- Ken Griffin's largest Q2 2022 buy was ResMed: 1,280,595 shares worth $268M.
- Ken Griffin added most to Meta Platforms (Facebook) in Q2 2022, an estimated $772M increase.
- Ken Griffin's biggest Q2 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $576M.
- Ken Griffin fully exited Vanguard Morningstar Small-Cap ETF in Q2 2022, selling an estimated $184M.
- Ken Griffin's ten largest holdings make up 28% of its $390B portfolio in Q2 2022.
- Ken Griffin opened 1,520 new positions and closed 2,191 in Q2 2022.
- Ken Griffin's portfolio value fell 20% quarter-over-quarter to $390B.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.